SOLUTION NMR

NMR Experiment
Experiment Type Sample Contents Ionic Strength Solvent pH Pressure Temprature (K)
1 3D 1H-15N NOESY 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
2 3D 1H-13C NOESY 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
3 3D 1H-15N NOESY (NOEs to lipid) 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
4 3D 1H-13C NOESY (methyl; double 13C-filter) 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
5 2D 1H-13C NOESY (aromatic; double 13C-filter) 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
6 2D 1H-15N HSQC 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
7 2D 1H-13C HSQC 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
8 3D HNCO 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
9 3D HNCA 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
10 3D HNCACB 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
11 3D CBCA(CO)NH 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
12 3D C(CO)NH 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
13 3D HBHA(CO)NH 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
14 3D HCCH-TOCSY 0.5 mM [U-13C; U-15N] mCD28CD-1, 100 mM POPG-2, 125 mM DHPC-3, 20 mM sodium phosphate-4, 10 % [U-2H] D2O-5, 90 % H2O-6, 90% H2O/10% D2O 20 90% H2O/10% D2O 6.7 ambient 300
NMR Spectrometer Information
Spectrometer Manufacturer Model Field Strength
1 Bruker AVANCE 600
NMR Refinement
Method Details Software
simulated annealing ? 1
NMR Ensemble Information
Conformer Selection Criteria structures with the least restraint violations
Conformers Calculated Total Number 200
Conformers Submitted Total Number 10
Representative Model 1 (fewest violations)
Computation: NMR Software
# Classification Version Software Name Author
1 collection 3.2 TopSpin Bruker Biospin
2 processing ? NMRPipe Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3 data analysis 5.2.2 NMRView Johnson, One Moon Scientific
4 data analysis 0.9843 KUJIRA Naohiro Kobayashi
5 structure solution 2.32 X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore
6 refinement 2.32 X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore